CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Ruchi P. Patel, Guido Ghilardi, Yunlin Zhang, Yi Hao Chiang, Wei Xie, Puneeth Guruprasad, Ki Hyun Kim, Inkook Chun, Mathew G. Angelos, Raymone Pajarillo, Seok Jae Hong, Yong Gu Lee, Olga Shestova, Carolyn Shaw, Ivan Cohen, Aasha Gupta, Trang Vu, Dean Qian, Steven Yang, Aditya NimmagaddaAdam E. Snook, Nicholas Siciliano, Antonia Rotolo, Arati Inamdar, Jaryse Harris, Ositadimma Ugwuanyi, Michael Wang, Alberto Carturan, Luca Paruzzo, Linhui Chen, Hatcher J. Ballard, Tatiana Blanchard, Chong Xu, Mohamed Abdel-Mohsen, Khatuna Gabunia, Maria Wysocka, Gerald P. Linette, Beatriz Carreno, David M. Barrett, David T. Teachey, Avery D. Posey, Daniel J. Powell, C. Tor Sauter, Stefano Pileri, Vinodh Pillai, John Scholler, Alain H. Rook, Stephen J. Schuster, Stefan K. Barta, Patrizia Porazzi, Marco Ruella*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'CD5 deletion enhances the antitumor activity of adoptive T cell therapies'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science